Business Context and Reporting Period
This Form 8-K Current Report from GRI Bio, Inc. (GRI) covers events occurring on August 13, 2025. The filing documents the results of the Company's 2025 Annual Meeting of Stockholders, held virtually. GRI Bio is an emerging growth company incorporated in Delaware with its principal executive offices in La Jolla, California.
Key Financial Metrics
This filing is a current report regarding corporate governance and equity plan amendments. It does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. Investors should refer to the Company's most recent Form 10-K or 10-Q for financial statements.
Material Changes and Corporate Actions
The following material actions were approved by stockholders at the Annual Meeting:
- Equity Plan Amendment: Stockholders approved an amendment to the Amended and Restated 2018 Equity Incentive Plan, increasing the number of shares reserved for issuance by 400,000 shares.
- Board Elections: Two Class II directors were elected to serve until the 2028 Annual Meeting:
- Roelof Rongen: 63,031 votes For, 3,068 Against, 331 Abstained.
- Camilla V. Simpson, M.Sc: 63,581 votes For, 2,519 Against, 330 Abstained.
- Auditor Ratification: Stockholders ratified the appointment of WithumSmith+Brown, PC as the independent registered public accounting firm for the fiscal year ending December 31, 2025 (1,072,167 votes For, 16,553 Against).
Outlook, Risks, and Management Commentary
The filing contains no forward-looking guidance, management commentary on business outlook, or discussion of specific risks or contingencies beyond the standard incorporation by reference of the Proxy Statement. The primary focus is the administrative approval of the equity plan amendment and the ratification of corporate officers and auditors.
Key Facts for Investor Verification
- Shareholder Participation: A quorum of 1,090,373 shares (approximately 43.67% of eligible shares) was present at the meeting.
- Broker Non-Votes: There were 1,023,943 broker non-votes recorded for the director elections and the equity plan amendment, indicating brokers did not vote on these matters for beneficial owners who did not provide instructions.
- Equity Dilution Potential: Verify the impact of the additional 400,000 shares reserved for the Equity Incentive Plan on potential future dilution.
- Full Plan Text: The complete text of the amended Equity Incentive Plan is available in Exhibit 10.1 of this filing.